Press release
Gastric Cancer Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
Gastric Cancer Market Size
The size of the gastric cancer market has been expanding swiftly in the last couple of years. It is projected to escalate from $3.17 billion in 2024 to $3.65 billion in 2025, experiencing a compound annual growth rate (CAGR) of 15.4%. The substantial growth during the historic period can be linked to an aging population, heightened healthcare awareness, the rise in genetic mutations, increasing adoption of unhealthy lifestyles, and a deeper understanding of cancer.
In the coming years, the market size of gastric cancer is anticipated to experience fast expansion. It is set to develop and reach $6.43 billion by 2029, growing at a compound annual growth rate (CAGR) of 15.2%. The surge in the projected period can be credited to factors such as increased obesity rates, expanded government efforts, higher healthcare investments, elevated demand for orally administered medications, and an increased number of facilities offering cancer treatment. The forecast period is characterized by trends like combined chemotherapy, product diversification, robotic-assisted surgeries, targeted treatment approaches, strategic partnerships, and the use of advanced diagnostic tools.
What Are the Primary Growth Drivers for the Gastric Cancer Market?
The escalating rates of obesity worldwide are predicted to push the growth of the gastric cancer market in the future. Defined as excessive accumulation of body fat, leading to a body mass index (BMI) of 30 or above, obesity poses numerous health risks. Factors such as inadequate diet, insufficient physical exercise, sedentary routines, environmental factors, and genetic predispositions contribute to the increasing obesity rates. High levels of body fat, especially visceral fat in the abdominal region, pose a higher risk of developing gastric cancer as it initiates chronic inflammation and metabolic abnormalities, both cancer triggers. This increases the demand for gastric cancer treatments. For example, in March 2024, the World Health Organization, a Switzerland-based international body, reported that about one in eight people worldwide suffered from obesity in 2022. This included 2.5 billion individuals aged 18 and above who were overweight, comprising 890 million individuals suffering with obesity. The stats also revealed that 43% of adults were overweight, with 16% being obese. Additionally, 37 million children below the age of 5 were overweight, and more than 390 million children and teenagers between 5-19 years were overweight, with 160 million being obese. Hence, due to the escalating obesity rates, the gastric cancer market is advancing.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20797&type=smp
Who Are the Dominant Companies Influencing Gastric Cancer Market Trends?
Major companies operating in the gastric cancer market are F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Samsung Biologics Co. Ltd., Celltrion Healthcare Co. Ltd., Biocon Limited, Hanmi Pharmaceuticals, Mylan N.V., Taiho Oncology Inc., Hikma Pharmaceuticals PLC, Taiho Pharmaceuticals Co. Ltd., AROG Pharmaceuticals Inc.
What Are the Major Trends Shaping the Gastric Cancer Market?
Prominent firms in the gastric cancer market are putting their effort towards the creation of high-tech solutions such as companion diagnostic assays, designed to promote individualized treatments. This specific type of diagnostic assay is utilized to pinpoint patients who will potentially receive the most advantage from certain therapeutic treatments, thanks to identifiable biomarkers. For example, in October 2024, the Switzerland-based pharmaceutical corporation, F. Hoffmann-La Roche Ltd., received approval from the U.S. Food and Drug Administration (FDA) for their VENTANA CLDN18 (43-14A) RxDx Assay. This marked the debut of the first immunohistochemistry (IHC) companion diagnostic designed to assess the expression of the CLDN18 protein within gastric and gastroesophageal junction (GEJ) adenocarcinoma. This assay spots patients who are suitable for targeted treatment with VYLOY (zolbetuximab) through the measurement of CLDN18 protein variants, predominantly CLDN18.2. The OptiView DAB IHC Detection Kit on the BenchMark ULTRA device is employed in this test to further advance personalized healthcare and broaden the scope of treatment for gastric and GEJ adenocarcinoma.
What Are the Different Segmentations in the Gastric Cancer Market?
The gastric cancer market covered in this report is segmented -
1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types
2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis
3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments
4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels
Subsegments:
1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma
2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma
3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST
4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3
5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report
Which Region Is at the Forefront of the Gastric Cancer Market?
North America was the largest region in the gastric cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Gastric Cancer Global Market Report?
- Market Size Analysis: Analyze the gastric cancer Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the gastric cancer Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall gastric cancer market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the gastric cancer market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20797
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastric Cancer Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share here
News-ID: 3875225 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Gastric
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Gastric Ulcers Market Size By 2025?
In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.…
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market?
The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,…
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market?
The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that…
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Gastric Cancer…
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market.
Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126
The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
The Virtual Gastric Band 101
There’s been a lot in the media recently about the Hypnotic Gastric Band or also known as The Virtual Gastric Band. I get asked a lot about it so thought I’d give a Virtual Gastric Band 101 on what it is, but more importantly what it’s not.
The Virtual Gastric Band - It is a non-surgical technique which uses the power of hypnosis to retrain the person to be satisfied with smaller…
